Product Offerings
Products:
Animal Health Biologicals: Poultry Vaccines, Swine Vaccines
Animal Health Pharmaceuticals: Antibiotic Therapy, Reproduction Control Products
Companion Animal Products: ADAPTIL, FELIWAY
CEVA ANIMAL HEALTH ASIA SDN BHD: Innovating Animal Health Solutions in Asia
CEVA Animal Health Asia Sdn Bhd is a subsidiary of Ceva Santé Animale, a global leader in veterinary pharmaceuticals and biologicals. Based in Kuala Lumpur, Malaysia, the company is committed to advancing animal health through innovative vaccines, pharmaceuticals, and companion animal solutions.
Core Business & Expertise
As part of Ceva’s global operations, CEVA Animal Health Asia specializes in:
- Biological Solutions – Vaccines for poultry and swine to prevent infectious diseases.
- Pharmaceuticals – Antibiotics and reproduction control products for livestock.
- Companion Animal Health – Behavioral health products such as ADAPTIL and FELIWAY for pets.
Through its research-driven approach, CEVA Animal Health Asia supports veterinarians, farmers, and pet owners with cutting-edge animal health solutions.
Unique Selling Proposition (USP)
- Global Leader in Animal Vaccines – Market leader in poultry and swine vaccines.
- Innovative Companion Animal Products – ADAPTIL and FELIWAY are globally recognized brands for pet behavioral health.
- Strong Research & Development – Continuous investment in new disease prevention solutions.
- Presence in Over 110 Countries – Serving animal health professionals worldwide.
- Sustainability and One Health Approach – Commitment to reducing antibiotic resistance and promoting animal welfare.
Financial Performance
Ceva Santé Animale, the parent company, reported a revenue of €1.5 billion in 2023, with a significant contribution from its Asia-Pacific operations. The company’s consistent growth underscores its strong market position and commitment to innovation.
International Presence & Shipment Data
CEVA Animal Health Asia has a robust distribution network across Southeast Asia, including key markets such as Malaysia, Thailand, Vietnam, and Indonesia. The company has been involved in millions of vaccine doses shipped annually to poultry and swine farms, ensuring disease prevention and livestock productivity.
Certifications & Compliance
CEVA Animal Health Asia adheres to the highest global regulatory standards:
- Good Manufacturing Practice (GMP) Certification – Ensuring product safety and efficacy.
- ISO 9001: Quality Management System – Compliance with international quality standards.
- OIE (World Organisation for Animal Health) Compliance – Supporting global animal disease control initiatives.
Client Testimonials
“CEVA’s poultry vaccines have significantly improved flock health, reducing mortality rates and boosting farm productivity.” – Leading Poultry Producer, Malaysia
“ADAPTIL has been a game-changer for pet owners dealing with stress-related behaviors in dogs.” – Veterinarian, Thailand
Major Achievements
- Top 5 Global Animal Health Company, with a strong footprint in Asia.
- Over 500 Million Poultry Vaccines distributed annually in the region.
- Expansion of Companion Animal Health Division, increasing pet wellness awareness.
- Continuous Investment in R&D, launching next-generation veterinary solutions.
CEVA Animal Health Asia remains at the forefront of veterinary innovation, enhancing animal well-being and supporting sustainable livestock production in Asia.